academic article

• A placebo-controlled randomized trial of D-cycloserine augmentation of cue exposure therapy for smoking cessation..  Cognitive Behaviour Therapy.  48:65-76. 2018
• Improved Depressive Symptoms in Adults with Schizophrenia During a Smoking Cessation Attempt with Varenicline and Behavioral Therapy..  Journal of Dual Diagnosis.  13:168-178. 2017
• Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy..  Addictive Behaviors.  89-95. 2017
• Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder..  Schizophrenia Research.  124-129. 2016
• Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial..  Journal of Clinical Psychiatry.  77:e320-6. 2016
• Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness.  J. Clin. Psychiatry.  2016
• Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial..  JAMA.  311:145-54. 2014